The Drugs Control Department has instructed drug retailers and wholesalers not to sell anti-viral drugs used for treating black fungus infection (mucormycosis) in COVID-19 patients without valid prescription.
The department also asked pharmaceutical traders to notify the Drugs Control Department about the sale and stock position of the anti-viral drug Amphoterecin B, the drug of choice in treating the potentially fatal fungal infection.
This is to prevent blackmarketing of the drug during a period of soaring demand.
Meanwhiile, the Health Department was allotted 1,000 vials of the anti-viral injection Remdesivir from the Centre.
T. Arun, Health Secretary said the drug was being administered judiciously to all patients who require it in the State and private hospitals.
Source: Read Full Article